scholarly journals A 28-year-old man with abdominal cramping pain and tarry stool for 6 months

2017 ◽  
Vol 4 (3) ◽  
pp. 117-118
Author(s):  
g-Yu Wei ◽  
Chung-Wang Ko ◽  
g-Zen Yeh ◽  
Cheng-Pin Wu ◽  
Chung-Hsin Chang ◽  
...  
Keyword(s):  
Tarry Stool

scholarly journals Safety of Regular-Dose Imatinib Therapy in Patients with Gastrointestinal Stromal Tumors Undergoing Dialysis

2016 ◽  
Vol 10 (1) ◽  
pp. 17-23 ◽  
Author(s):  
Ryota Niikura ◽  
Takako Serizawa ◽  
Atsuo Yamada ◽  
Shuntaro Yoshida ◽  
Mariko Tanaka ◽  
...  
Keyword(s):  
Gastrointestinal Stromal Tumors ◽  
Imatinib Treatment ◽  
Efficacy And Safety ◽  
Tarry Stool ◽  
Dialysis Patients ◽  
Stromal Tumors ◽  
Duodenal Gist ◽  
Johnson Syndrome ◽  
Old Japanese ◽  
Steven Johnson Syndrome

The number of cancer patients undergoing dialysis has been increasing, and the number of these patients on chemotherapy is also increasing. Imatinib is an effective and safe therapy for KIT-positive gastrointestinal stromal tumors (GIST), but the efficacy and safety of imatinib in dialysis patients remain unclear. Because clinical trials have not been conducted in this population, more investigations are required. We report on a 75-year-old Japanese man undergoing dialysis who presented with massive tarry stool from a duodenal GIST. The duodenal GIST was 14 cm in diameter with multiple liver and bone metastases. The patient underwent an urgent pancreaticoduodenectomy to achieve hemostasis. After surgery, he was administered imatinib 400 mg/day. No severe adverse event including myelosuppression, congestive heart failure, liver functional impairment, intestinal pneumonia, or Steven-Johnson syndrome occurred, and the liver metastasis remained stable for 4 months. During chemotherapy, hemodialysis continued three times per week without adverse events. We suggest that regular-dose imatinib is an effective and safe treatment in patients with GIST undergoing dialysis. In addition, we present a literature review of the effectiveness and safety of imatinib treatment in dialysis patients.

A CASE OF SQUAMOUS CELL CARCINOMA OF THE PANCREAS WITH AN INITIAL SYMPTOM OF TARRY STOOL

2001 ◽  
Vol 16 (9) ◽  
pp. 1077-1079 ◽  
Author(s):  
Takeshi Minami ◽  
Kenji Fukui ◽  
Yasukazu Morita ◽  
Shinya Kondo ◽  
Yoshikazu Ohmori ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Initial Symptom ◽  
Tarry Stool ◽  
Carcinoma Of The Pancreas

Tarry Stool in a Man With Acute Pancreatitis

2012 ◽  
Vol 143 (2) ◽  
pp. e5-e6
Author(s):  
Wen-Hung Hsu ◽  
Chao-Hung Kuo ◽  
Jee-Fu Huang
Keyword(s):  
Acute Pancreatitis ◽  
Tarry Stool

scholarly journals A Case of Gastric Antral Vascular Ectasia Which Was Aggravated by Acid Reducer

2017 ◽  
Vol 11 (1) ◽  
pp. 64-71 ◽  
Author(s):  
Yukiomi Nakade ◽  
Tomonori Ozeki ◽  
Hiroyuki Kanamori ◽  
Tadahisa Inoue ◽  
Takaya Yamamoto ◽  
...  
Keyword(s):  
Linear Array ◽  
Argon Plasma ◽  
Term Effect ◽  
Laser Coagulation ◽  
Gastric Antral Vascular Ectasia ◽  
Tarry Stool ◽  
Vascular Ectasia ◽  
First Case ◽  
Long Term Effect

Gastric antral vascular ectasia (GAVE) is known to be characterized by red patches or spots in a diffuse or linear array in the antrum of the stomach. The precise etiology of GAVE remains to be elucidated. Argon plasma laser coagulation (APC) has been used to control oozing from GAVE; however, there is no satisfactory long-term effect of APC in the control of oozing from GAVE. An acid reducer is used after APC because even physiological acid exposure might delay post-APC ulcer healing. We describe the case of a patient who had used an acid reducer and experienced repeated gastrointestinal hemorrhage due to GAVE. After ceasing to administer the acid reducer, incidences of hospitalization due to oozing from GAVE stopped. After the administration of the acid reducer was restarted, the patient had tarry stool, and diffuse oozing of blood was seen again. We report a first case of GAVE which was aggravated by acid reducer.

scholarly journals BRUNNER'S GLAND TUMOR OF THE DUODENUM WITH ANEMIA AND TARRY STOOL : REPORT OF TWO CASES

1993 ◽  
Vol 43 (5) ◽  
pp. 575-579
Author(s):  
YUKIO KOIBUCHI ◽  
SHIGEYUKI MINAGUCHI ◽  
OSAMU TESHIGAWARA ◽  
YUKITAKA YAMAGISHI ◽  
TOMOMICHI TSUKUI ◽  
...  
Keyword(s):  
Tarry Stool ◽  
Gland Tumor ◽  
Brunner’S Gland ◽  
Brunner's Gland

scholarly journals A Case of Metastatic Gastric Malignant Melanoma Diagnosed by Massive Tarry Stool

1993 ◽  
Vol 43 (0) ◽  
pp. 163-165
Author(s):  
Mari Saito ◽  
Mikio Matsuoka ◽  
Kohki Mitsuya ◽  
Masahiko Takao ◽  
Kotaroh Matsuyama ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Tarry Stool

A rare cause of tarry stool and ileus

2015 ◽  
Vol 82 (2) ◽  
pp. 415-417
Author(s):  
Wei-Fan Hsu ◽  
Cheng-Yu Lo ◽  
Chen-Shuan Chung
Keyword(s):  
Tarry Stool

scholarly journals Utility of Dual Red Imaging for Endoscopic Hemostasis of Gastric Ulcer Bleeding

2019 ◽  
Vol 38 (4) ◽  
pp. 352-354
Author(s):  
Yoko Kubosawa ◽  
Hideki Mori ◽  
Ai Fujimoto
Keyword(s):  
Atrial Fibrillation ◽  
Gastric Ulcer ◽  
White Light ◽  
Hypovolemic Shock ◽  
Ulcer Bleeding ◽  
Tarry Stool ◽  
Surrounding Area ◽  
Bleeding Point ◽  
New Type ◽  
White Light Imaging

Dual red imaging (DRI; Red Dichromatic Imaging (RDI)) is a new type of image-enhanced endoscopy composed of two long wavelengths that together can visualize vessels in the deep submucosa of the gastrointestinal wall. We treated a case of gastric ulcer bleeding in which the bleeding point could be clearly visualized using DRI. A 71-year-old man who was taking warfarin for atrial fibrillation noticed tarry stool, entered a state of hypovolemic shock, and underwent emergency esophagogastroduodenoscopy. The procedure was performed with a GIF-Y0058 prototype endoscope (Olympus Co., Tokyo, Japan) equipped with a DRI mode. An ulcer with active bleeding was found in the upper portion of the stomach, but the massive volume of the bleeding made it difficult to identify the bleeding point using white light imaging (WLI). Upon switching to DRI mode by pushing a button on the endoscope, the bleeding point could be identified rapidly and precisely, as it appeared in a deeper yellow than the surrounding area. Complete hemostasis was thereupon achieved. This case demonstrates that the DRI mode may be useful for detecting bleeding points that are difficult to detect using WLI.

scholarly journals Proton Pump Inhibitor-Associated Large Hyperplastic Polyp in Non-Helicobacter pylori-Infected Stomach

2021 ◽  
pp. 539-544
Author(s):  
Kimitoshi Kubo ◽  
Noriko Kimura ◽  
Norishige Maiya ◽  
Soichiro Matsuda ◽  
Momoko Tsuda ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Proton Pump Inhibitor ◽  
Proton Pump ◽  
Hyperplastic Polyp ◽  
Gastric Body ◽  
Tarry Stool ◽  
Transnasal Endoscopy ◽  
Pedunculated Polyp ◽  
Greater Curvature ◽  
H Pylori

A proton pump inhibitor (PPI)-associated hyperplastic polyp (HP) in the non-<i>Helicobacter pylori</i>-infected stomach is rare, and its endoscopic features remain poorly described. A 42-year-old man with tarry stool was referred to our hospital for examination and treatment. He had taken PPI for 14 years and was confirmed to be <i>H. pylori</i>-negative. Transnasal endoscopy revealed bleeding from a 20-mm, reddish pedunculated polyp with a nodular surface, located in the greater curvature of the upper gastric body. Endoscopic mucosal resection was performed, and the lesion was diagnosed as an HP. To our knowledge, this report represents a valuable addition to the HP literature describing a rare case of PPI-associated large HP in the non-<i>H. pylori</i>-infected stomach.

Sign in / Sign up

Export Citation Format

Share Document